TGFB1 and cancer: Given the potent inhibition of TGFβ-induced changes in morphology, motility and epithelial/mesenchymal marker expression, RAC1B is likely to also impact other EMT-associated responses, such as cancer stem cell generation and apoptosis sensitivity/chemoresistance.